Use of patient-reported outcomes to measure symptoms and health related quality of life in the clinic
A Gilbert, D Sebag-Montefiore, S Davidson… - Gynecologic …, 2015 - Elsevier
There is increasing interest in the use of patient-reported outcomes (PROs) in routine
practice in cancer care to measure symptoms and health related quality of life (HRQOL) …
practice in cancer care to measure symptoms and health related quality of life (HRQOL) …
Using clinical practice variations as a method for commissioners and clinicians to identify and prioritise opportunities for disinvestment in health care: a cross-sectional …
C Beynon, W Hollingworth, L Rooshenas… - Health Services and …, 2015 - pure.qub.ac.uk
Background NHS expenditure has stagnated since the economic crisis of 2007, resulting in
financial pressures. One response is for policy-makers to regulate use of existing health …
financial pressures. One response is for policy-makers to regulate use of existing health …
First steps in PROMs and PREMs collection in Wales as part of the prudent and value-based healthcare agenda
K Withers, R Palmer, S Lewis, G Carolan-Rees - Quality of life research, 2021 - Springer
Purpose Patients are experts in their own health and should be treated as equal partners in
their care. Patient-reported outcome measures (PROMs) are an effective way of gathering …
their care. Patient-reported outcome measures (PROMs) are an effective way of gathering …
The use of patient-reported outcome measures to guide referral for hip and knee arthroplasty: part 1: the development of an evidence-based model linking …
Aims To calculate how the likelihood of obtaining measurable benefit from hip or knee
arthroplasty varies with preoperative patient-reported scores. Methods Existing UK data from …
arthroplasty varies with preoperative patient-reported scores. Methods Existing UK data from …
The responsiveness of patient-reported outcome tools in shoulder surgery is dependent on the underlying pathological condition
RZ Unger, JM Burnham, L Gammon… - … American journal of …, 2019 - journals.sagepub.com
Background: Given the high number of available patient-reported outcome (PRO) tools for
patients undergoing shoulder surgery, comparative information is necessary to determine …
patients undergoing shoulder surgery, comparative information is necessary to determine …
The Irish cost-effectiveness threshold: does it support rational rationing or might it lead to unintended harm to Ireland's health system?
JF O'Mahony, D Coughlan - Pharmacoeconomics, 2016 - Springer
Ireland is one of the few countries worldwide to have an explicit cost-effectiveness threshold.
In 2012, an agreement between government and the pharmaceutical industry that provided …
In 2012, an agreement between government and the pharmaceutical industry that provided …
Estimation of an EORTC QLU-C10 value set for Spain using a discrete choice experiment
Abstract Background The EORTC QLU-C10D is a preference-based measure derived from
the EORTC QLQ-C30. For use in economic evaluations, country-specific value sets are …
the EORTC QLQ-C30. For use in economic evaluations, country-specific value sets are …
Cost-effectiveness applications of patient-reported outcome measures (proms) in spine surgery
TJ Lee, AA Thomas, NR Grandhi, MS Galetta… - Clinical Spine …, 2020 - journals.lww.com
Because of the rising health care costs in the United States, there has been a focus on value-
based care and improving the cost-effectiveness of surgical procedures. Patient-reported …
based care and improving the cost-effectiveness of surgical procedures. Patient-reported …
Technology assessment and cost-effectiveness in orthopedics: how to measure outcomes and deliver value in a constantly changing healthcare environment
JM Burnham, F Meta, V Lizzio, EC Makhni… - Current reviews in …, 2017 - Springer
Purpose of review The purpose of this study is to review the basic concepts of healthcare
value, patient outcome measurement, and cost-effectiveness analyses as they relate to the …
value, patient outcome measurement, and cost-effectiveness analyses as they relate to the …
Cost-effectiveness of ranibizumab versus aflibercept in the treatment of visual impairment due to diabetic macular edema: a UK healthcare perspective
SA Régnier, W Malcolm, J Haig… - … and Outcomes Research, 2015 - Taylor & Francis
Background Ranibizumab and aflibercept are alternative anti-vascular endothelial growth
factor agents approved for the treatment of visual impairment (VI) due to diabetic macular …
factor agents approved for the treatment of visual impairment (VI) due to diabetic macular …